Merrill Lynch Takes Bullish Stance on Cannabis Testing Industry

Bank of America Merrill Lynch recently released a new biotechnology report focused on medical cannabis called “Medical cannabis has high POTential: a joint biotech & tools primer”. In the report, the analyst takes a detailed look at the current medical marijuana landscape and the various companies operating within it, while being bullish on the overall cannabis testing market and the growth prospects for tools within it.

The report mentions a number of cannabis testing companies:

“Cannabis testing market in the US consists primarily of small providers of testing and consulting services. Some of the leading cannabis testing and consulting services providers include: Steep Hill Labs, CannLabs (OTC: CANL), DigiPath (OTC: DIGP), Signal Bay (OTC: SGBY), The Werc Shop, and Green Standards Diagnostics. Due to rapidly evolving and potentially conflicting legislation enacted on a state by state basis, the cannabis testing industry is subject to disruptive changes. Competition is based on...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.